INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

BEAMBeam Therapeutics Inc.

CIK 0001745999

EDGAR filingsOpen in network
Disclosed transactions1
Buys / sells0 / 1
Max Insider Score26
Connections4with evidence

BEAM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
ARK Investment Management LLC13F filer
BEAMBeam Therapeutics Inc.
TRIM
SELL$65.16M
1.90M sh
Not disclosedAug 14, 2026quarterlySEC 13F

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Lobbied forevidence
    AVIVA STRATEGIES (FKA MGB CONSULTING)LDA 2TY 2026 second quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    GRIDIRON PUBLIC AFFAIRS, LLCLDA RR 2026 second quarter · Health issues · Aug 26, 2026
  • ← Holdsevidence
    ARK Investment Management LLC
2.3% of reported portfolio · Aug 14, 2026

Lobbying

$10K reported · de-duplicated
2026 Q2 $10K via firms2026 Q1 $0 via firms
  • AVIVA STRATEGIES (FKA MGB CONSULTING)—2026 Q1 · posted Aug 26, 2026 ·
  • GRIDIRON PUBLIC AFFAIRS, LLC$10K2026 Q2 · posted Aug 26, 2026 · Health issues
  • GRIDIRON PUBLIC AFFAIRS, LLC—2026 Q2 · posted Aug 26, 2026 · Health issues
  • AVIVA STRATEGIES (FKA MGB CONSULTING)—2026 Q2 · posted Aug 26, 2026 ·

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.